PCR134 Uncertainties in Evaluating Patient and Caregiver Health-Related Quality of Life and Disease Burden in NICE HST Submissions
0
Citation
0
Reference
10
Related Paper
Keywords:
Nice
Excellence
Caregiver Burden
Proxy (statistics)
Cite
Citations (120)
Nice
Excellence
Caregiver Burden
Proxy (statistics)
Cite
Citations (0)
Nice
Excellence
Economic Evaluation
EQ-5D
Cost–utility analysis
Health Technology
Cite
Citations (0)
Cite
Citations (0)
This paper uses the Disability Adjusted Life Year (DALY) to estimate disease burden at a local level and relates this to programme budget (PB) data.We estimated DALY using the global burden of disease (GBD) template. For years of life lost, local mortality data were used and for years of life with disability, the GBD estimates from World Health Organization EURO A region (including the UK) were used. We used PB data to analyse how healthcare expenditure matched disease burden.In 2005 the burden of disease in Lambeth was estimated at 36,368 DALYs (13,515 DALYs lost per 100,000) and in Southwark was 34,196 DALYs (13,244 DALYs lost per 100,000). There were gender and area differences. The ranking is different when mortality and morbidity are combined compared with mortality alone. We estimated that the average spend per DALY lost in 2005 was 11,066 pounds in Lambeth and 9390 pounds in Southwark.We used a pragmatic approach to estimate overall disease burden providing a local, more comprehensive picture with important differences in spend by disease and health authority area. However, a more detailed approach to support decisions about prioritization based on modelling interventions that impact on avoidable burden of disease is recommended.
Disability-adjusted life year
Prioritization
Cite
Citations (29)
Harris' reply to our defence of the National Institute for Clinical Excellence's (NICE) current cost-effectiveness procedures contains two further errors. First, he wrongly draws a conclusion from the fact that NICE does not and cannot evaluate all possible uses of healthcare resources at any one time and generally cannot know which National Health Service (NHS) activities would be displaced or which groups of patients would have to forgo health benefits: the inference is that no estimate is or can be made by NICE of the benefits to be forgone. This is a non-sequitur. Second, he asserts that it is a flaw at the heart of the use of quality-adjusted life years (QALYs) as an outcome measure that comparisons between people need to be made. Such comparisons do indeed have to be made, but this is not a consequence of the choice of any particular outcome measure, be it the QALY or anything else.
Nice
Excellence
Health care rationing
Cite
Citations (19)
It is extremely important to objectively take a view of population health to provide useful information to decision makers, health-sector leaders, researchers, and informed citizens. This study aims to examine the burden of disease in Korea as of 2015, and to study how the burden of disease changes with the passage of time.We used results from the Korean National Burden of Disease and Injuries Study 2015 for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive disability-adjusted life years (DALYs) by gender and age groups from 2007 to 2015. DALYs were calculated as the sum of the years of life lost (YLLs) and the years lived with disability (YLDs).In 2015, the burden of disease for Korean people was calculated at 29,476 DALYs per 100,000 population. DALYs caused by low back pain were the highest, followed by diabetes mellitus and chronic obstructive pulmonary disease. The burden of disease showed a consistently increasing trend from 2007 to 2015. Although YLLs have been on the decrease since 2011, the increase in YLDs has contributed to the overall rise in DALYs. The DALYs per 100,000 population in 2015 increased by 28.1% compared to 2007.As for the diseases for which the burden of disease is substantially increasing, it is needed to establish appropriate policies in a timely manner. The results of this study are expected to be the basis for prioritizing public health and health care policies in Korea.
Disability-adjusted life year
Cite
Citations (72)
Cite
Citations (0)
Nice
Excellence
Health Economics
Health Technology
Economic Evaluation
Cite
Citations (57)
Indicators which help us evaluate the burden of a disease and its related health interventions include financial cost, mortality, and morbidity.1 Quality-adjusted life year (QALY) and disability-adjusted life year (DALY) are two indicators that quantify the total number of years lost because of illness.2 One DALY is equal to one year of healthy life lost, and disease burden is a measure of the gap between current health status and the ideal health status.3 These indicators help us compare disease burdens, and have also been used to forecast the possible impacts of health interventions.3 However, as a limitation, DALY is a generalization of a multifaceted reality, and consequently, provides a rough indication of health impact.4 The consideration of only DALY is not enough for policy makers to base health care plans upon. Policy makers pay the greatest attention to the highest DALYs; however, the presence of lower DALYs, as the major contributing factors of disease burden, should not be ignored. For instance, maternal death maintains a high disease burden, and prevention of coughs in infants does not receive enough financial support.4
Disability-adjusted life year
Cite
Citations (2)